Skip to main content

Table 3 Association of the CJIE1 prophage and the CJIE1 prophage carrying ORF 11 with patient symptoms

From: Effects of the Campylobacter jejuniCJIE1 prophage homologs on adherence and invasion in culture, patient symptoms, and source of infection

Symptoms

Patients with symptoms (%) versus total

Association of C. jejunistrain characteristics with symptoms: number associated with patient and symptom vs total (%)

  

No CJIE1 (%)

CJIE1 only (%)

CJIE1 + ORF 11

Diarrhea

214/218 (98.2)

158/162 (97.5)

16/16 (100)

15/15 (100)

Abdominal pain

169/204 (83.0)

127/153 (83.0)

9/16 (56.3)

12/15 (80.0)

Fever

134/219 (61.2)

107/146 (73.3)

4/16 (25.0)

6/14 (42.9)

Malaise

127/199 (63.8)

95/145 (65.5)

9/16 (56.3)

9/14 (64.3)

Nausea

113/205 (57.5)

87/151 (57.6)

8/16 (50.0)

9/14 (64.3)

Headache

91/201 (45.3)

70/142 (49.3)

7/16 (43.8)

4/11 (36.4)

Bloody diarrhea

49/145 (33.7)

33/99 (33.3)

4/15 (26.7)

8/14 (57.1)

Vomiting

73/214 (34.1)

56/157 (35.7)

3/16 (18.8)

5/14 (35.7)

Duration > 10 days

33/137 (24.1)

35/102 (34.3)

2/10 (20.0)

3/9 (33.3)

Hospitalization

15/142 (10.6)

10/125 (6.6)

1/13 (7.7)

2/13 (15.4)

  1. Note that there were different response rates for different questions, resulting in different denominators. “Patients with symptoms” refers to the number of patients having the particular symptom compared with the total number of patients answering the question yes or no on the questionnaire. This column provides data on the overall frequency of symptoms. Isolates for further analysis were not available for all patients answering the comprehensive questionnaire. Data in the section “Association of C. jejuni strain characteristics with symptoms…” contains symptom information from patients from whom isolates were obtained and were typed. The frequencies with which each symptom was associated with the presence of absence of the CJIE1 prophage and also the presence within the CJIE prophage of ORF11 have been compared to determine whether either CJIE1 alone or CJIE1 with ORF11 have any significant effect on patient symptoms compared with absence of the prophage.